The abstract is read at the publisher; the summary is JClub's.
X-chromosome dosage differences in Turner syndrome (45X) and Klinefelter syndrome (47XXY) are closely associated with cardiometabolic burden and increased MASLD risk, independent of sex hormone levels.
- Why it matters: Sex-related MASLD differences are often explained mainly by sex hormones, but this hormone-only view may miss an important biological driver.
- What they did: The article synthesizes evidence from comparisons of TS and KS versus euploid controls and cites transcriptomic findings showing genome-wide, dosage-sensitive regulatory effects of X-chromosome quantity.
- The result: Framing TS and KS as liver disease models suggests X-chromosome dosage actively reprograms cardiometabolic and hepatic pathways, guiding future research on sex-specific MASLD heterogeneity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.